SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-21-000045
Filing Date
2021-05-07
Accepted
2021-05-07 16:52:19
Documents
88
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20210331.htm   iXBRL 10-Q 1417559
2 EX-31.1 supn-20210331x10qxex311.htm EX-31.1 9782
3 EX-31.2 supn-20210331x10qxex312.htm EX-31.2 10502
4 EX-32.1 supn-20210331x10qxex321.htm EX-32.1 5024
5 EX-32.2 supn-20210331x10qxex322.htm EX-32.2 5051
  Complete submission text file 0001356576-21-000045.txt   7663590

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20210331.xsd EX-101.SCH 52402
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20210331_cal.xml EX-101.CAL 123320
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20210331_def.xml EX-101.DEF 301435
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20210331_lab.xml EX-101.LAB 676684
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20210331_pre.xml EX-101.PRE 464453
11 EXTRACTED XBRL INSTANCE DOCUMENT supn-20210331_htm.xml XML 1301704
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 21903640
SIC: 2834 Pharmaceutical Preparations